Committee for Orphan Medicinal Products (COMP): 8-9 April 2014
Date:
08/04/2014 to 09/04/2014
Location:
European Medicines Agency, London, UK
The Committee for Orphan Medicinal Products (COMP) is the committee that is responsible for reviewing applications for 'orphan medicinal product designation' for medicines intended for the diagnosis, prevention or treatment of rare diseases.
-
List item
Minutes of the COMP meeting 8-9 April 2014 (PDF/248.47 KB)
Adopted
First published: 16/06/2014
Last updated: 18/06/2014
EMA/COMP/151064/2014 Rev. 1 -
List item
COMP meeting report on the review of applications for orphan designation: April 2014 (PDF/129.44 KB)
First published: 14/04/2014
Last updated: 14/04/2014
EMA/COMP/189040/2014 -
List item
Agenda - COMP agenda of the 8-9 April 2014 meeting (PDF/108.03 KB)
First published: 28/03/2014
Last updated: 28/03/2014
EMA/COMP/179739/2014